[Assessment of oral health using the general oral health assessment index in patients with overactive bladder].
Patients administered anti-cholinergic agents, as first-line therapy for an overactive bladder (OAB) are often unable to continue medical treatment because of dry mouth. We assessed oral health in patients with OAB using the General Oral Health Assessment Index (GOHAI), an oral health-related quality of life questionnaire. We investigated 75 patients with OAB who were receiving continuous administration of anti-cholinergic agents. The OAB symptom score, as well as GOHAI and our original dry mouse score were determined by self-administered questionnaires. The mean age of the subjects was 70.9±10.2 years, the median period of anti-cholinergic agent use was 20 (1-116) months and the mean OAB symptom score was 6.3±3.1. The GOHAI score for all patients was 51.9±8.4 and not significantly different from the national normal value (p＝0.22). On the other hand, the score in patients with a severely dry mouth was 49.2±8.6, which was worse than the national normal value (p＝0.04). The psychosocial functioning score in patients with a severely dry mouth was significantly lower than in those with a slightly dry mouth (p＝0.02). Our results indicate that dry mouth in patients with OAB is significantly associated with worsening of oral health. GOHAI is useful as a screening test to assess the quality of life in patients with OAB.
The Department of Urology, Hyogo College of Medicine, Japan.
Rikiya
R
Taoka
Hiromitsu
H
Kishimoto
Takeshi
T
Hanasaki
Toueki
T
Yo
Yukako
Y
Nakanishi
Yusuke
Y
Shiraishi
Yoshikazu
Y
Togo
Toru
T
Suzuki
Atsushi
A
Nakao
Yoshihide
Y
Higuchi
Akihiro
A
Kanematsu
Michio
M
Nojima
Shingo
S
Yamamoto
D000368:Aged; D018680:Cholinergic Antagonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009909:Oral Health; D011788:Quality of Life; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000503:physiopathology*; D014987:Xerostomia / Q000139:chemically induced*
D018680:Cholinergic Antagonists